Research and Markets: MediPoint: Cardiac Rhythm Management - US Analysis and Market Forecasts

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/nls35r/medipoint) has announced the addition of the "MediPoint: Cardiac Rhythm Management - US Analysis and Market Forecasts" report to their offering.

Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the heart's electrical system, and are related to cardiac dyssynchrony.

While medication can be effective in mild to moderate cases, patients with more severe conditions must turn to device use or surgical intervention in order to receive the therapy they require. Over the years, CRM device treatment has become less invasive, and significant advances in pacing and pulse generator technology have enabled effective long-term device therapy with limited complications.

Reimbursement in the US continues to be a problem, largely because not all procedures are covered, and because not all patients have insurance. Especially in the wake of the 2008 recession, affordability is a huge concern with patients who don't have health insurance, and CRM adoption rates have been limited by issues with reimbursement.

Scope

- An overview of hypertension, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.

- Annualized the US CRM market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.

- Investigation of current and future market competition for CRM

- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.

- Competitor assessment including device approval analysis and device sales forecasts.

- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.

- Analysis of unmet needs within the market and opportunities for future players.

- Technology trends evaluation to assess strength of pipeline.

- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.

- Company profiles including business description, financial overview and SWOT analysis.

- Coverage of key market players.

- Strategic assessment of the CRM sector through market impact analysis, future market scenario and company analysis.

- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists

Key Topics Covered:

1.1 List of Tables

1.2 List of Figures

2 Introduction

3 Disease Overview

4 Industry Overview

5 Competitive Assessment

6 Unmet Needs

7 Pipeline Products

8 Current and Future Players

9 Market Outlooks and Forecasts

10 Appendix

1.1 List of Tables

1.2 List of Figures

Companies Mentioned

Biotronik

Boston Scientific

Impulse Dynamics

Medtronic

Sorin Group

St. Jude Medical

For more information visit http://www.researchandmarkets.com/research/nls35r/medipoint.

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices